Aggrastat is a medication used to prevent blood clots from forming in patients who are undergoing a procedure called percutaneous coronary intervention (PCI) or in those with unstable angina (chest pain). It is a type of medication called a glycoprotein IIb/IIIa inhibitor, which works by preventing platelets in the blood from sticking together and forming clots.
The generic name for Aggrastat is tirofiban hydrochloride. Tirofiban hydrochloride is a small molecule that binds specifically to the glycoprotein IIb/IIIa receptor on platelets, inhibiting their aggregation and reducing the risk of blood clots.